Radiation & ADT: Sexual Effects
External-Beam/Brachytherapy and Androgen-Deprivation Therapy on Erection, Libido, and Orgasm
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- FDA Approved (radiation & ADT agents)
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about radiation & adt: sexual effects in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Non-surgical prostate-cancer treatment has its own distinct sexual fingerprint. Radiation (external-beam or brachytherapy) tends to preserve erections better than surgery in the short term but causes a gradual decline over 2-5 years as radiation-induced vascular fibrosis and neural injury accumulate, so long-term ED rates can converge with surgery. Androgen-deprivation therapy (ADT), GnRH agonists/antagonists, sometimes added to radiation in intermediate/high-risk disease, collapses testosterone to castrate levels and devastates libido, erectile function, and orgasm, while adding hot flashes, fatigue, muscle/bone loss, and metabolic effects. Combining radiation with ADT compounds the sexual burden.
Surgery damages erections quickly; radiation damages them slowly; ADT removes the desire underneath.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Radiation deposits dose in the periprostatic neurovascular bundles and corporal inflow vessels; the resulting endothelial damage and progressive fibrosis impair the NO/cGMP-dependent inflow needed for erection, which is why the decline is delayed and progressive rather than immediate. ADT works upstream of the gonads: GnRH agonists desensitize the pituitary (after an initial flare) and antagonists block it directly, dropping LH and testicular testosterone to castrate levels. Because libido and the central drive for sexual arousal are androgen-dependent, ADT removes desire itself, not just the mechanics, a qualitatively different injury from surgery or radiation alone.
Three different injuries, three different counseling messages
Patients and even clinicians often lump 'prostate cancer treatment' into one sexual-side-effect bucket, but the three modalities injure different things. Surgery is an acute nerve/structural injury with immediate loss of erection and permanent dry orgasm. Radiation is a slow vascular/neural injury with delayed, progressive ED. ADT is a hormonal injury that erases libido and can blunt or abolish orgasm and shrink the genitals, and its effects may persist after the drug stops, with testosterone recovery being slow and sometimes incomplete, especially in older men or after long ADT courses. Orgasm changes (anorgasmia, painful or diminished orgasm) are common across all three and are among the least-counseled outcomes.
Safety in detail
Radiation and ADT are oncologic treatments with significant, sometimes permanent sexual and systemic effects requiring specialist oversight. ADT additionally affects bone, muscle, metabolism, and cardiovascular and cognitive health.
What people get wrong
Often saidRadiation spares your sex life
ActuallyIt spares it better than surgery early on, but ED rises progressively over years and long-term rates can match surgery.
Often saidTestosterone bounces right back after ADT
ActuallyRecovery is slow and sometimes incomplete, particularly after prolonged ADT or in older men.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- Optimal timing/duration of ADT to balance oncologic benefit against sexual and metabolic harm.
- Whether intermittent ADT meaningfully spares sexual function versus continuous.
At a glance
- Radiation ED onset
- Gradual, over ~2-5 years
- Mechanism
- Vascular fibrosis + neural injury
- ADT effect
- Castrate testosterone -> loss of libido, ED, orgasm change
- Common ADT drugs
- Leuprolide, goserelin, degarelix; antiandrogens
- Recovery after ADT
- Testosterone may partly recover months-years after stopping; not always full
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Radiation & ADT: Sexual Effects. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Sanda et al., PROST-QA, NEJM2008
Quantified treatment-specific sexual quality-of-life trajectories: surgery worst early, radiation declining later, ADT worsening hormonal/sexual domains
Bolla et al., EORTC radiation+ADT trials2010
Established survival benefit of adding long-course ADT to radiation in high-risk disease, at the cost of sexual and systemic toxicity
Resnick et al., long-term comparative outcomes, NEJM2013
At 15 years, sexual dysfunction was high and converged across surgery and radiation